Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels

Clinical Cardiology

Volumn 22, Issue 2, 1999, Pages 113-117

  Etoh, Takuma ^a   Kato, Johji ^a   Takenaga, Makoto ^a   Imamura, Takuroh ^a   Kitamura, Kazuo ^a   Koiwaya, Yasushi ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; Heart failure; Natriuretic peptides; Proadrenomedullin N terminal 20 peptide

Indexed keywords

ADRENOMEDULLIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE; PEPTIDE; PROADRENOMEDULLIN; PROADRENOMEDULLIN AMINO TERMINAL 20 PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RESPONSE; CATECHOLAMINE RELEASE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEART FAILURE; HEART INFARCTION; HEART RIGHT ATRIUM PRESSURE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; SYMPATHETIC NERVE; VALVULAR HEART DISEASE;

EID: 0032983342     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960220211     Document Type: Article

References (21)

1. Kitamura K, Eto T: Adrenomedullin - physiological regulator of the cardiovascular system or biochemical curiosity? Curr Opin Nephrol Hypertens 1997;6:80-87
2. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T: Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993;241:271-273
3. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest 1995;96:1672-1676
4. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994;338:6-10
5. Washimine H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K, Matsuo H, Eto T: Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem Biophys Res Commun 1994;202:1081-1087
6. The Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. New York Heart Association/Little, Brown and Company, 1994
7. Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, Sakakibara S, Kangawa K, Matsuo H, Eto T: Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994;341:288-290
8. Matsumoto A, Hirata Y, Momomura S, Suzuki E, Yokoyama I, Sata M, Ohtani Y, Serizawa T: Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 1995;129:139-145
9. Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T: Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81:180-183
10. 2+-dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett 1994;348:61-64
11. Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, Kangawa K, Yamamoto Y, Kobayashi H, Eto T, Wada A: Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: Its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995;64:459-461
12. Ishihara T, Kato J, Kitamura K, Katoh F, Fujimoto S, Kangawa K, Eto T: Production of adrenomedullin in human vascular endothelial cells. Life Sci 1997;60:1763-1769
13. Ishiyama Y, Kitamura K, Ichiki Y, Sakata J, Kida O, Kangawa K, Eto T: Hemodynamic responses to rat adrenomedullin in anesthetized spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995;22:614-618
14. Braunwald E: Pathophysiology of heart failure. In Heart Disease: A Textbook of Cardiovascular Medicine, 4th ed., p. 393-418. Philadelphia: W.B. Saunders, 1992
15. Needleman P, Blaine EH, Greenwald JE, Michener ML, Saper CB, Stockmann PT, Tolunay HE: The biochemical pharmacology of atrial peptides. Ann Rev Pharmacol Toxicol 1989;29:23-54
16. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inoue K, Imura H: Brain natriuretic peptide as a novel cardiac hormone in humans : Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-1412
17. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994;94:2158-2161
18. Kato J, Kitamura K, Kuwasako K, Tanaka M, Ishiyama Y, Shimokubo T, Ichiki Y, Nakamura S, Kangawa K, Eto T: Plasma adrenomedullin in patients with primary aldosteronism. Am J Hypertens 1995;8:997-1000
19. Ebara T, Miura K, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H: Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994;263:69-73
20. Shimosawa T, Fujita T: Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension 1996;28:325-329
21. Niina H, Kobayashi H, Kitamura K, Katoh F, Eto T, Wada A: Inhibition of catecholamine synthesis by proadrenomedullin N-terminal 20 peptide in cultured bovine adrenal medullary cells. Eur J Pharmacol 1995;286:95-97